Cargando…
Estrogen receptor β inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy
BACKGROUND: Estrogen receptor β (ERβ) has been reported to play an anti-cancer role in breast cancer, but the regulatory mechanism by which ERβ exerts this effect is not clear. Claudin-6 (CLDN6), a tight junction protein, acts as a tumor suppressor gene in breast cancer. Our previous studies have fo...
Autores principales: | Song, Peiye, Li, Yanru, Dong, Yuan, Liang, Yingying, Qu, Huinan, Qi, Da, Lu, Yan, Jin, Xiangshu, Guo, Yantong, Jia, Yiyang, Wang, Xinqi, Xu, Wenhong, Quan, Chengshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694553/ https://www.ncbi.nlm.nih.gov/pubmed/31412908 http://dx.doi.org/10.1186/s13046-019-1359-9 |
Ejemplares similares
-
A SUMOylation-dependent HIF-1α/CLDN6 negative feedback mitigates hypoxia-induced breast cancer metastasis
por: Jia, Yiyang, et al.
Publicado: (2020) -
CLDN6 promotes chemoresistance through GSTP1 in human breast cancer
por: Yang, Minlan, et al.
Publicado: (2017) -
ERα is required for suppressing OCT4‐induced proliferation of breast cancer cells via DNMT1/ISL1/ERK axis
por: Jin, Xiangshu, et al.
Publicado: (2019) -
SMAD2 Inactivation Inhibits CLDN6 Methylation to Suppress Migration and Invasion of Breast Cancer Cells
por: Lu, Yan, et al.
Publicado: (2017) -
OCT4 maintains self-renewal and reverses senescence in human hair follicle mesenchymal stem cells through the downregulation of p21 by DNA methyltransferases
por: Lu, Yan, et al.
Publicado: (2019)